150 Participants Needed

Intensive Transition Support for Medically Complex Youth

(PITCare Trial)

SS
Overseen BySara Santos
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: The Hospital for Sick Children
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on providing support during the transition to adult care, so it's best to ask the trial coordinators for more details.

What data supports the effectiveness of the treatment Intensive Transition Support for Medically Complex Youth?

Research shows that coordinated care models can improve health outcomes for children with medical complexity during transitions. Additionally, interventions focusing on hospital-to-home transitions have been linked to better life impact and resource use outcomes, suggesting that structured support can be beneficial.12345

Is Intensive Transition Support for Medically Complex Youth safe for humans?

The available research highlights the importance of coordinated care and communication for children with medical complexity, but it does not provide specific safety data for Intensive Transition Support. Families of these children often identify safety and quality gaps in hospital care, suggesting that while the approach aims to improve transitions, safety concerns may still exist.14678

How is the Intensive Transition Support treatment different from other treatments for medically complex youth?

The Intensive Transition Support treatment is unique because it focuses on providing coordinated care and support during the transition from pediatric to adult care for medically complex youth, addressing both physical and mental challenges. This approach aims to improve health outcomes by easing the transition process, which is often complex due to differences in pediatric and adult healthcare systems.19101112

What is the purpose of this trial?

Medical advances have allowed many more children and youth with medical complexity (CMC) to survive well into adulthood. However, this has not been matched with increases in knowledge of complex conditions or the availability of supports as they transition into the adult care system. The goal of this randomized control trial is to compare intensive transition support from a transition team, led by an advance practice nurse, during transition to adult care for 2 years, with usual care in CMC. Participants assigned to the intervention group will be offered support in care planning, receiving funding, and connecting with a primary care provider and adult subspecialists.The main questions it aims to answer are:1. Does intensive transition support improve the patient's continuity of care over 2 years compared with usual care?2. Will there be differences between intervention and control groups with respect to other outcomes related to the youth/family's satisfaction with care, care coordination, self-care, health service utilization, cost-effectiveness, and quality of life?3. What are the experiences of youth, parents, the transition team, and other clinicians involved in the intensive transition support process?

Eligibility Criteria

This trial is for children and youth with complex medical needs who rely on technology, face severe or life-threatening conditions, expect their condition to last at least 6 months, and are involved with multiple healthcare teams in various locations. It's not specified who can't join.

Inclusion Criteria

You have a complex involvement of at least five healthcare practitioners/teams and healthcare services in three or more locations, including home, school, hospital, etc.
You have a serious and/or potentially fatal medical condition.
The condition is expected to persist for a minimum of 6 months.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intensive Transition Support

Participants receive intensive transition support from a transition team, led by an advance practice nurse, during transition to adult care

24 months
Regular visits as needed for transition support

Follow-up

Participants are monitored for continuity of care, satisfaction, and other outcomes after transition support

12 months

Treatment Details

Interventions

  • Intensive Transition Support
Trial Overview The study tests if intensive support during the shift from pediatric to adult care improves continuity of care over two years versus usual care. Support includes help with care plans, funding access, and connecting with primary providers and specialists.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: Control/ Usual CareActive Control1 Intervention
Standard of care in the control group will involve the utilization of existing tools within clinical programs which may include preparation for transitions, but there will be no systematic follow-up by a paediatric provider beyond age 18. Care will be transferred to adult providers (primary care and specialists) via a transition guide that will be offered to participants and their referring providers. This is the current model of care for virtually all CMC in Ontario.

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Hospital for Sick Children

Lead Sponsor

Trials
724
Recruited
6,969,000+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

Findings from Research

Transitions in care for children with medical complexity (CMC) and their parents often lead to emotional distress and high expectations, highlighting the psychological challenges faced during these periods.
However, when collaborative models of care are implemented, CMC experience improvements in quality of life and emotional health after transitioning from hospital to home, indicating the potential benefits of coordinated care approaches.
Changes in Care- A Systematic Scoping Review of Transitions for Children with Medical Complexities.Mantler, T., Jackson, KT., Baer, J., et al.[2021]
A study involving 29 parents and 37 healthcare professionals identified 25 important and feasible transitional care interventions for children with medical complexity, focusing on family engagement, care coordination, and education.
The expert elicitation process revealed that while both parents and healthcare professionals agreed on the importance of these interventions, healthcare professionals were generally more cautious about their feasibility compared to parents.
Importance and Feasibility of Transitional Care for Children With Medical Complexity: Results of a Multistakeholder Delphi Process.Leyenaar, JK., Rizzo, PA., Khodyakov, D., et al.[2020]
This systematic review analyzed 50 studies and identified 172 outcomes related to hospital-to-home transitions for children with medical complexity, ultimately categorizing them into 25 unique outcomes across six domains, including mortality, physical health, and life impact.
The findings highlight significant variability in both the outcomes reported and the methods used to measure them, suggesting a need for standardized outcome measures to improve the evaluation of transitional care interventions for these children.
Hospital-to-home transitions for children with medical complexity: part 1, a systematic review of reported outcomes.de Lange, A., Alsem, MW., Haspels, HN., et al.[2023]

References

1.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Changes in Care- A Systematic Scoping Review of Transitions for Children with Medical Complexities. [2021]
Importance and Feasibility of Transitional Care for Children With Medical Complexity: Results of a Multistakeholder Delphi Process. [2020]
Hospital-to-home transitions for children with medical complexity: part 1, a systematic review of reported outcomes. [2023]
Stakeholder perspectives: Communication, care coordination, and transitions in care for children with medical complexity. [2022]
Complex Care Hospital Use and Postdischarge Coaching: A Randomized Controlled Trial. [2020]
Strategies to support transitions from hospital to home for children with medical complexity: A scoping review. [2018]
Parent Perceptions and Experiences Regarding Medication Education at Time of Hospital Discharge for Children With Medical Complexity. [2021]
In their own words: Safety and quality perspectives from families of hospitalized children with medical complexity. [2023]
Transition to adult care for youth with medical complexity: Assessing needs and setting priorities for a health care improvement initiative. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Effectiveness of Structured Care Coordination for Children With Medical Complexity: The Complex Care for Kids Ontario (CCKO) Randomized Clinical Trial. [2023]
A Novel Hospital-to-Home System for Children With Medical Complexities: Usability Testing Study. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Health Services and Health Care Needs Fulfilled by Structured Clinical Programs for Children with Medical Complexity. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security